The Gap, Inc. (GAP) 10-Q 26 Nov 24 2024 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Nov. 02, 2024	Nov. 19, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Nov. 02, 2024
Document Transition Report	false
Entity File Number	1-7562
Entity Registrant Name	GAP, INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-1697231
Entity Address, Address Line One	Two Folsom Street
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94105
City Area Code	415
Local Phone Number	427-0100
Title of 12(b) Security	Common Stock, $0.05 par value
Trading Symbol	GAP
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		377,121,870
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000039911
Current Fiscal Year End Date	--02-01
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) shares in Millions, $ in Millions	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Current assets:
Cash and cash equivalents	$ 1,969	$ 1,873	$ 1,351
Short-term investments	250	0	0
Merchandise inventory	2,331	1,995	2,377
Other current assets	580	527	646
Total current assets	5,130	4,395	4,374
Property and equipment, net of accumulated depreciation	2,546	2,566	2,552
Operating Lease, Right-of-Use Asset	3,217	3,115	3,200
Other long-term assets	960	968	926
Total assets	11,853	11,044	11,052
Current liabilities:
Accounts payable	1,523	1,349	1,433
Accrued expenses and other current liabilities	1,135	1,108	1,078
Operating Lease, Liability, Current	617	600	604
Income taxes payable	50	39	24
Total current liabilities	3,325	3,096	3,139
Long-term liabilities:
Total long-term debt	1,489	1,488	1,488
Operating Lease, Liability, Noncurrent	3,360	3,353	3,456
Lease incentives and other long-term liabilities	544	512	509
Total long-term liabilities	$ 5,393	$ 5,353	$ 5,453
Common stock, shares outstanding (in shares)	377	372	371
Stockholders' equity:
Authorized 2,300 shares for all periods presented	$ 19	$ 19	$ 18
Additional Paid in Capital	177	113	93
Retained earnings	2,889	2,420	2,291
Amounts reclassified from accumulated other comprehensive income	50	43	58
Total stockholders' equity	3,135	2,595	2,460
Liabilities and Equity	$ 11,853	$ 11,044	$ 11,052
Common stock, shares issued (in shares)	377	372	371
Common stock, shares authorized (in shares)	2,300	2,300	2,300
Common stock, par value (in dollars per share)	$ 0.05	$ 0.05	$ 0.05

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) shares in Millions, $ in Millions	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Property and equipment, accumulated depreciation	$ 4,985	$ 4,874	$ 4,890
Common stock, par value (in dollars per share)	$ 0.05	$ 0.05	$ 0.05
Common stock, shares authorized (in shares)	2,300	2,300	2,300

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Net Sales	$ 3,829	$ 3,767	$ 10,937	$ 10,591
Cost of goods sold and occupancy expenses	2,194	2,211	6,322	6,488
Gross profit	1,635	1,556	4,615	4,103
Operating Expenses	1,280	1,306	3,762	3,757
Operating income (loss)	355	250	853	346
Interest Expense	23	28	68	66
Interest income	(29)	(28)	(80)	(58)
Income (Loss) before income taxes	361	250	865	338
Income taxes	87	32	227	21
Net income (loss)	$ 274	$ 218	$ 638	$ 317
Weighted-average number of shares - basic (in shares)	377	371	376	369
Weighted-average number of shares - diluted (in shares)	383	375	383	373
Earnings (loss) per share - basic (in dollars per share)	$ 0.73	$ 0.59	$ 1.70	$ 0.86
Earnings (loss) per share - diluted (in dollars per share)	$ 0.72	$ 0.58	$ 1.67	$ 0.85

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Net income (loss)	$ 274	$ 218	$ 638	$ 317
Other comprehensive income (loss), net of tax:
Foreign currency translation	(3)	5	0	1
Change in fair value of derivative financial instruments, net of tax (tax benefit)	5	16	11	22
Reclassification adjustment for (gains) losses on derivative financial instruments, net of (tax) tax benefit	(3)	(7)	(4)	(13)
Other comprehensive income (loss), net of tax	(1)	14	7	10
Comprehensive income (loss)	$ 273	$ 232	$ 645	$ 327

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Change in fair value of derivative financial instruments, net of tax (tax benefit)	$ 1	$ 1	$ 6	$ 3
Reclassification adjustment for (gains) losses on derivative financial instruments, net of (tax) tax benefit	$ (1)	$ 1	$ (6)	$ 0

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Stock options Common Stock [Member]	Stock Units [Member] Common Stock [Member]
Common stock, shares issued (in shares)		366
Stockholders' Equity Attributable to Parent	$ 2,233	$ 18	$ 27	$ 2,140	$ 48
Net income (loss)	317			317
Other Comprehensive Income (Loss), Net of Tax	10				10
Stock Issued During Period, Shares, Other						2	3
Stock Issued During Period, Value, Other	18	0	18
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation	(16)	$ 0	(16)
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	$ 64		64
Common Stock, Dividends, Per Share, Declared	$ 0.45
Dividends, Cash	$ (166)			(166)
Common stock, shares issued (in shares)		369
Stockholders' Equity Attributable to Parent	2,263	$ 18	73	2,128	44
Net income (loss)	218			218
Other Comprehensive Income (Loss), Net of Tax	14				14
Stock Issued During Period, Shares, Other						1	1
Stock Issued During Period, Value, Other	5	0	5
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation	(5)	$ 0	(5)
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	$ 20		20
Common Stock, Dividends, Per Share, Declared	$ 0.15
Dividends, Cash	$ (55)			(55)
Common stock, shares issued (in shares)	371	371
Stockholders' Equity Attributable to Parent	$ 2,460	$ 18	93	2,291	58
Common stock, shares issued (in shares)	372	372
Stockholders' Equity Attributable to Parent	$ 2,595	$ 19	113	2,420	43
Net income (loss)	638			638
Other Comprehensive Income (Loss), Net of Tax	7				7
Stock Issued During Period, Shares, Other						2	3
Stock Issued During Period, Value, Other	27	0	27
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation	(48)	$ 0	(48)
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	$ 85		85
Common Stock, Dividends, Per Share, Declared	$ 0.45
Dividends, Cash	$ (169)			(169)
Common stock, shares issued (in shares)		376
Stockholders' Equity Attributable to Parent	2,901	$ 19	159	2,672	51
Net income (loss)	274			274
Other Comprehensive Income (Loss), Net of Tax	(1)				(1)
Stock Issued During Period, Shares, Other						1	0
Stock Issued During Period, Value, Other	6	0	6
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation	(15)	$ 0	(15)
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	$ 27		27
Common Stock, Dividends, Per Share, Declared	$ 0.15
Dividends, Cash	$ (57)			(57)
Common stock, shares issued (in shares)	377	377
Stockholders' Equity Attributable to Parent	$ 3,135	$ 19	$ 177	$ 2,889	$ 50

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023
Cash flows from operating activities:
Net income (loss)	$ 638	$ 317
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	371	394
Share-based compensation	85	64
Non-cash and other items	(4)	41
Gain (Loss) on Disposition of Property Plant Equipment	0	47
Deferred income taxes	17	(27)
Changes in operating assets and liabilities:
Merchandise inventory	(344)	(5)
Other current assets and other long-term assets	(35)	81
Accounts payable	156	133
Accrued expenses and other current liabilities	29	(11)
Income taxes payable, net of receivables and other tax-related items	50	50
Lease incentives and other long-term liabilities	(18)	(11)
Operating lease assets and liabilities, net	(75)	(147)
Net cash provided by (used for) operating activities	870	832
Cash flows from investing activities:
Purchases of property and equipment	(330)	(288)
Net proceeds from sale of building	0	76
Purchases of short-term investments	(343)	0
Proceeds from sales and maturities of short-term investments	97	0
Net proceeds from divestiture activity, net of cash paid	0	9
Net cash provided by (used for) investing activities	(576)	(203)
Cash flows from financing activities:
Repayments of revolving credit facility	0	(350)
Proceeds from issuances under share-based compensation plans	27	18
Withholding tax payments related to vesting of stock units	(48)	(16)
Cash dividends paid	(169)	(166)
Other	(3)	(2)
Net cash provided by (used for) financing activities	(193)	(516)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(4)	(7)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	97	106
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents beginning of period	1,901	1,273
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents end of period	1,998	1,379
Supplemental disclosure of cash flow information:
Cash paid for interest during the period	61	72
Cash paid for income taxes during the period, net of refunds	$ 173	$ (1)

Accounting Policies

Accounting Policies	9 Months Ended
	Nov. 02, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Accounting Policies [Text Block]	Accounting Policies Basis of Presentation In the opinion of The Gap, Inc. (the “Company,” “we,” and “our”) management, the accompanying unaudited Condensed Consolidated Financial Statements contain all normal and recurring adjustments (except as otherwise disclosed) considered necessary to present fairly our financial position, results of operations, comprehensive income, stockholders' equity, and cash flows as of November 2, 2024 and October 28, 2023 and for all periods presented. The Condensed Consolidated Balance Sheet as of February 3, 2024 has been derived from our audited financial statements. The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission. Accordingly, certain information and disclosures normally included in the notes to the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been omitted from these interim financial statements, although the Company believes that the disclosures made are adequate to make the information not misleading. We suggest that you read these Condensed Consolidated Financial Statements in conjunction with the Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended February 3, 2024. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates. Additionally, these estimates and assumptions may change as a result of the impact of global economic conditions such as the uncertainty regarding global inflationary pressures, acts of terrorism or war, global credit and banking markets, and the geopolitical landscape including new legislation and the potential impacts of recent elections. We will continue to consider the impact of the global economic conditions on the assumptions and estimates used when preparing these Condensed Consolidated Financial Statements including inventory valuation, income taxes and valuation allowances, sales return and bad debt allowances, deferred revenue, and the impairment of long-lived assets. If the global economic conditions change beyond what is currently estimated by management, such future changes may have an adverse impact on the Company's results of operations and financial position. Restricted Cash As of November 2, 2024, February 3, 2024, and October 28, 2023, restricted cash primarily included consideration that serves as collateral for our insurance obligations and certain other obligations occurring in the normal course of business. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within our Condensed Consolidated Balance Sheets to the total shown on our Condensed Consolidated Statements of Cash Flows: ($ in millions) November 2, February 3, October 28, Cash and cash equivalents, per Condensed Consolidated Balance Sheets $ 1,969 $ 1,873 $ 1,351 Restricted cash included in other long-term assets 29 28 28 Total cash, cash equivalents, and restricted cash, per Condensed Consolidated Statements of Cash Flows $ 1,998 $ 1,901 $ 1,379 Accounting Pronouncements Except as noted below, the Company has considered all recent accounting pronouncements and concluded that there are no recent accounting pronouncements that may have a material impact on our Condensed Consolidated Financial Statements and disclosures, based on current information. Accounting Pronouncement Recently Adopted ASU No. 2022-04, Disclosure of Supplier Finance Program Obligations In September 2022, the Financial Accounting Standards Board ("FASB") issued accounting standards update ("ASU") No. 2022-04, Disclosure of Supplier Finance Program Obligations. The ASU is intended to enhance the transparency of the use of supplier finance programs by requiring additional disclosures about the program’s nature and potential magnitude, including a rollforward of the obligations and activity during the period. The ASU is effective retrospectively for fiscal years and interim periods within those years beginning after December 15, 2022, except for the amendment on rollforward information, which is effective prospectively for fiscal years beginning after December 15, 2023. The ASU does not affect the recognition, measurement, or financial statement presentation of supplier finance program obligations. We adopted the required guidance on January 29, 2023. See Note 12 of Notes to Condensed Consolidated Financial Statements for information regarding our supply chain finance program. Accounting Pronouncements Not Yet Adopted ASU No. 2023-07, Improvements to Reportable Segment Disclosures In November 2023, the FASB issued ASU No. 2023-07, Improvements to Reportable Segment Disclosures. The ASU is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The ASU is effective retrospectively for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. We are currently assessing the impact that this ASU will have on the Company's disclosures. ASU No. 2023-09, Improvements to Income Tax Disclosures In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures. The ASU is intended to improve the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the rate reconciliation, as well as income taxes paid disaggregated by jurisdiction. The ASU is effective for annual periods beginning after December 15, 2024 and should be applied on a prospective basis, but retrospective application is permitted. We are currently assessing the impact that this ASU will have on the Company's disclosures. ASU No. 2024-03, Disaggregation of Income Statement Expenses In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses. The ASU is intended to improve financial reporting by requiring disaggregated disclosure of certain costs and expenses. The ASU is effective for fiscal years beginning after December 15, 2026 and for interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The ASU may be applied on either a prospective or retrospective basis. We are currently assessing the impact that this ASU will have on the Company's disclosures.

Revenue

Revenue - USD ($) $ in Millions	9 Months Ended
	Nov. 02, 2024	Apr. 30, 2022
Revenue from Contract with Customer [Abstract]
Liabilities, Other than Long-term Debt, Noncurrent		$ 60
Revenue from Contract with Customer [Text Block]	Revenue We disaggregate our net sales by channel and also by brand and region. Net sales by region are allocated based on the location of the store where the customer paid for and received the merchandise; the distribution center or store from which the products were shipped; or the region of the franchise or licensing partner. Net sales disaggregated by channel are as follows: 13 Weeks Ended 39 Weeks Ended ($ in millions) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Store and franchise sales $ 2,289 $ 2,331 $ 6,871 $ 6,771 Online sales (1) 1,540 1,436 4,066 3,820 Total net sales $ 3,829 $ 3,767 $ 10,937 $ 10,591 __________ (1) Online sales primarily include sales originating from our online channel including those that are picked up or shipped from stores and net sales from revenue-generating strategic initiatives. Net sales disaggregated by brand and region are as follows: ($ in millions) Old Navy Global Gap Global Banana Republic Global Athleta Global Other (2) Total 13 Weeks Ended November 2, 2024 U.S. (1) $ 1,949 $ 683 $ 406 $ 281 $ 21 $ 3,340 Canada 190 95 43 9 — 337 Other regions 11 121 20 — — 152 Total $ 2,150 $ 899 $ 469 $ 290 $ 21 $ 3,829 ($ in millions) Old Navy Global Gap Global Banana Republic Global Athleta Global Other (2) Total 13 Weeks Ended October 28, 2023 U.S. (1) $ 1,917 $ 664 $ 398 $ 267 $ 15 $ 3,261 Canada 193 96 42 10 — 341 Other regions 16 127 20 2 — 165 Total $ 2,126 $ 887 $ 460 $ 279 $ 15 $ 3,767 ($ in millions) Old Navy Global Gap Global Banana Republic Global Athleta Global Other (2) Total 39 Weeks Ended November 2, 2024 U.S. (1) $ 5,663 $ 1,775 $ 1,203 $ 926 $ 49 $ 9,616 Canada 495 238 122 29 — 884 Other regions 31 341 63 2 — 437 Total $ 6,189 $ 2,354 $ 1,388 $ 957 $ 49 $ 10,937 ($ in millions) Old Navy Global Gap Global Banana Republic Global Athleta Global Other (2) Total 39 Weeks Ended October 28, 2023 U.S. (1) $ 5,353 $ 1,702 $ 1,187 $ 903 $ 29 $ 9,174 Canada 503 233 122 33 — 891 Other regions 59 399 63 5 — 526 Total $ 5,915 $ 2,334 $ 1,372 $ 941 $ 29 $ 10,591 __________ (1) U.S. includes the United States and Puerto Rico. (2) Primarily consists of net sales from revenue-generating strategic initiatives. We defer revenue when cash payments are received in advance of performance for unsatisfied obligations related to our gift cards, licensing agreements, outstanding loyalty points, and reimbursements of loyalty program discounts associated with our credit card agreement. For the 13 weeks ended November 2, 2024, the opening balance of deferred revenue for these obligations was $280 million, of which $95 million was recognized as revenue during the period. For the 39 weeks ended November 2, 2024, the opening balance of deferred revenue for these obligations was $337 million, of which $209 million was recognized as revenue during the period. The closing balance of deferred revenue for these obligations was $260 million as of November 2, 2024. For the 13 weeks ended October 28, 2023, the opening balance of deferred revenue for these obligations was $327 million, of which $119 million was recognized as revenue during the period. For the 39 weeks ended October 28, 2023, the opening balance of deferred revenue for these obligations was $354 million, of which $227 million was recognized as revenue during the period. The closing balance of deferred revenue for these obligations was $315 million as of October 28, 2023. In April 2021, the Company entered into agreements with Barclays and Mastercard relating to a long-term credit card program. The Company received an upfront payment of $60 million related to the agreements prior to the program launch in May 2022, which is being recognized as revenue over the term of the agreements. We also receive revenue sharing from our credit card agreement for private label and co-branded credit cards.

Income Taxes

Income Taxes	9 Months Ended
	Nov. 02, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The effective income tax rate was 24.1 percent for the 13 weeks ended November 2, 2024, compared with 12.8 percent for the 13 weeks ended October 28, 2023. The increase is primarily due to changes in valuation allowances in the prior year. The effective income tax rate was 26.2 percent for the 39 weeks ended November 2, 2024, compared with 6.2 percent for the 39 weeks ended October 28, 2023. The increase is primarily due to tax benefits recognized in the prior year from a U.S. transfer pricing settlement related to our sourcing activities, changes in valuation allowances in the prior year, current year increases to certain income tax reserves, and changes in the amount and mix of jurisdictional earnings, partially offset by a favorable impact from stock-based compensation.

Debt and Credit Facilities

Debt and Credit Facilities	9 Months Ended
	Nov. 02, 2024
Debt Disclosure [Abstract]
Debt and Credit Facilities	Debt and Credit Facilities Long-term debt recorded on the Condensed Consolidated Balance Sheets consists of the following: ($ in millions) November 2, February 3, October 28, 2029 Notes $ 750 $ 750 $ 750 2031 Notes 750 750 750 Less: Unamortized debt issuance costs (11) (12) (12) Total long-term debt $ 1,489 $ 1,488 $ 1,488 The scheduled maturity of the Senior Notes is as follows: Scheduled Maturity ($ in millions) Principal Interest Rate Interest Payments October 1, 2029 (1) $ 750 3.625 % Semi-Annual October 1, 2031 (2) 750 3.875 % Semi-Annual Total issuance $ 1,500 __________ (1) On or after October 1, 2024, includes an option to redeem the 2029 Notes, in whole or in part at any time, at stated redemption prices. (2) Includes an option to redeem the 2031 Notes, in whole or in part at any time, subject to a make-whole premium, prior to October 1, 2026. On or after October 1, 2026, includes an option to redeem the 2031 Notes, in whole or in part at any time, at stated redemption prices. We have $1.5 billion aggregate principal amount of 3.625 percent senior notes due 2029 (“2029 Notes”) and 3.875 percent senior notes due 2031 (“2031 Notes”) (the 2029 Notes and the 2031 Notes, collectively, the “Senior Notes”). As of November 2, 2024, the aggregate estimated fair value of the Senior Notes was $1.31 billion and was based on the quoted market prices for each of the Senior Notes (level 1 inputs) as of the last business day of the fiscal quarter. The aggregate principal amount of the Senior Notes is recorded in long-term debt on the Condensed Consolidated Balance Sheets, net of the unamortized debt issuance costs. We also have a senior secured asset-based revolving credit agreement (the "ABL Facility"), which has a $2.2 billion borrowing capacity and generally bears interest at a per annum rate based on Secured Overnight Financing Rate ("SOFR") (subject to a zero floor) plus a margin, depending on borrowing base availability. The ABL Facility is scheduled to expire in July 2027. The ABL Facility is available for working capital, capital expenditures, and other general corporate purposes. There were no borrowings under the ABL Facility as of November 2, 2024, February 3, 2024, or October 28, 2023.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Nov. 02, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company categorizes financial assets and liabilities recorded at fair value based upon a three-level hierarchy that considers the related valuation techniques. There were no material purchases, sales, issuances, or settlements related to recurring level 3 measurements for the 13 and 39 weeks ended November 2, 2024 or October 28, 2023. Financial assets and liabilities measured at fair value on a recurring basis and cash equivalents are as follows: Fair Value Measurements at Reporting Date Using ($ in millions) November 2, 2024 Quoted Prices in Significant Other Significant Assets: Cash equivalents $ 8 $ 1 $ 7 $ — Short-term investments 250 130 120 — Derivative financial instruments 19 — 19 — Deferred compensation plan assets 38 38 — — Other assets 4 — — 4 Total $ 319 $ 169 $ 146 $ 4 Liabilities: Derivative financial instruments $ 1 $ — $ 1 $ — Fair Value Measurements at Reporting Date Using ($ in millions) February 3, 2024 Quoted Prices in Significant Other Significant Assets: Cash equivalents $ 1 $ — $ 1 $ — Derivative financial instruments 7 — 7 — Deferred compensation plan assets 31 31 — — Other assets 4 — — 4 Total $ 43 $ 31 $ 8 $ 4 Liabilities: Derivative financial instruments $ 8 $ — $ 8 $ — Fair Value Measurements at Reporting Date Using ($ in millions) October 28, 2023 Quoted Prices in Significant Other Significant Assets: Cash equivalents $ 1 $ — $ 1 $ — Derivative financial instruments 34 — 34 — Deferred compensation plan assets 31 31 — — Other assets 4 — — 4 Total $ 70 $ 31 $ 35 $ 4 Liabilities: Derivative financial instruments $ — $ — $ — $ — We have highly liquid fixed and variable income investments classified as cash equivalents and short-term investments. All highly liquid investments with original maturities of three months or less at the time of purchase are classified as cash and cash equivalents on the Condensed Consolidated Balance Sheets. Our cash equivalents are placed primarily in debt securities which are recorded at fair value using market prices for identical or similar assets and time deposits which are recorded at amortized cost. We also have highly liquid investments with original maturities of greater than three months and less than two years that are classified as short-term investments on the Condensed Consolidated Balance Sheet. These debt securities are also recorded at fair value using market prices for identical or similar assets. There were no material realized or unrealized gains or losses or impairment charges related to short-term investments during the 13 and 39 weeks ended November 2, 2024. Derivative financial instruments primarily include foreign exchange forward contracts. See Note 6 of Notes to Condensed Consolidated Financial Statements for information regarding currencies hedged against the U.S. dollar. We maintain the Gap, Inc. Deferred Compensation Plan (“DCP”), which allows eligible employees to defer base compensation and bonus up to a maximum percentage, and non-employee directors to defer receipt of a portion of their Board fees. Plan investments are directed by participants and are recorded at market value and designated for the DCP. The fair value of the Company’s DCP assets is determined based on quoted market prices, and the assets are recorded in other long-term assets on the Condensed Consolidated Balance Sheets. Nonfinancial Assets We review the carrying amount of long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The fair value of the long-lived assets is determined using level 3 inputs and based on discounted future cash flows of the asset or asset group using a discount rate commensurate with the risk. The asset group is defined as the lowest level for which identifiable cash flows are available and largely independent of the cash flows of other groups of assets, which for our retail stores is at the store level. There were no material impairment charges recorded for long-lived assets during the 13 and 39 weeks ended November 2, 2024 or October 28, 2023. We review the carrying amount of goodwill and other indefinite-lived intangible assets for impairment annually and whenever events or changes in circumstances indicate that it is more likely than not that the carrying amount may not be recoverable. There were no impairment charges recorded for goodwill or other indefinite-lived intangible assets for the 13 and 39 weeks ended November 2, 2024 or October 28, 2023.

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Nov. 02, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments We operate in foreign countries, which exposes us to market risk associated with foreign currency exchange rate fluctuations. We use derivative financial instruments to manage our exposure to foreign currency exchange rate risk and do not enter into derivative financial contracts for trading purposes. Consistent with our risk management guidelines, we hedge a portion of our transactions related to merchandise purchases for foreign operations and certain intercompany transactions using foreign exchange forward contracts. These contracts are entered into with large, reputable financial institutions that are monitored for counterparty risk. The currencies hedged against changes in the U.S. dollar are the Canadian dollar, Japanese yen, British pound, New Taiwan dollar, and Euro. Cash flows from derivative financial instruments are classified as cash flows from operating activities on the Condensed Consolidated Statements of Cash Flows. Derivative financial instruments are recorded at fair value on the Condensed Consolidated Balance Sheets as other current assets, other long-term assets, accrued expenses and other current liabilities, or other long-term liabilities. Cash Flow Hedges We designate foreign exchange forward contracts used to hedge forecasted merchandise purchases and related costs denominated in U.S. dollars made by our international subsidiaries whose functional currencies are their local currencies as cash flow hedges. The foreign exchange forward contracts entered into to hedge forecasted merchandise purchases and related costs generally have terms of up to 24 months. The effective portion of the gain or loss on the derivative financial instruments is reported as a component of other comprehensive income (loss) and is recognized into net income during the period in which the underlying transaction impacts the Condensed Consolidated Statements of Operations. Other Derivatives Not Designated as Hedging Instruments We use foreign exchange forward contracts to hedge our market risk exposure associated with foreign currency exchange rate fluctuations for certain intercompany balances denominated in currencies other than the functional currency of the entity with the intercompany balance. The gain or loss on the derivative financial instruments that represent economic hedges, as well as the remeasurement impact of the underlying intercompany balances, is recorded in operating expenses on the Condensed Consolidated Statements of Operations in the same period and generally offset each other. Outstanding Notional Amounts We had foreign exchange forward contracts outstanding in the following notional amounts: ($ in millions) November 2, February 3, October 28, Derivatives designated as cash flow hedges $ 458 $ 381 $ 357 Derivatives not designated as hedging instruments 427 568 526 Total $ 885 $ 949 $ 883 Quantitative Disclosures about Derivative Financial Instruments The fair values of foreign exchange forward contracts are as follows: ($ in millions) November 2, February 3, October 28, Derivatives designated as cash flow hedges: Other current assets $ 10 $ 6 $ 13 Other long-term assets 1 — 2 Accrued expenses and other current liabilities — 2 — Derivatives not designated as hedging instruments: Other current assets 8 1 19 Accrued expenses and other current liabilities 1 6 — Total derivatives in an asset position $ 19 $ 7 $ 34 Total derivatives in a liability position $ 1 $ 8 $ — The majority of the unrealized gains and losses from designated cash flow hedges as of November 2, 2024 will be recognized in income within the next 12 months at the then-current values, which may differ from the fair values as of November 2, 2024 shown above. Our foreign exchange forward contracts are subject to master netting arrangements with each of our counterparties and such arrangements are enforceable in the event of default or early termination of the contract. We do not elect to offset the fair values of our derivative financial instruments on the Condensed Consolidated Balance Sheets, and as such, the fair values shown above represent gross amounts. The amounts subject to enforceable master netting arrangements were not material for all periods presented. See Note 5 of Notes to Condensed Consolidated Financial Statements for disclosures on the fair value measurements of our derivative financial instruments. The pre-tax amounts recognized in net income related to derivative instruments are as follows: Location and Amount of Gain 13 Weeks Ended 13 Weeks Ended ($ in millions) Cost of goods sold and occupancy expenses Operating expenses Cost of goods sold and occupancy expenses Operating expenses Total amount of expense line items presented in the Condensed Consolidated Statements of Operations in which the effects of derivatives are recorded $ 2,194 $ 1,280 $ 2,211 $ 1,306 Gain recognized in net income Derivatives designated as cash flow hedges (4) — (6) — Derivatives not designated as hedging instruments — (4) — (27) Total gain recognized in net income $ (4) $ (4) $ (6) $ (27) Location and Amount of Gain 39 Weeks Ended 39 Weeks Ended ($ in millions) Cost of goods sold and occupancy expense Operating expenses Cost of goods sold and occupancy expense Operating expenses Total amount of expense line items presented in the Condensed Consolidated Statements of Operations in which the effects of derivatives are recorded $ 6,322 $ 3,762 $ 6,488 $ 3,757 Gain recognized in net income Derivatives designated as cash flow hedges (10) — (13) — Derivatives not designated as hedging instruments — (17) — (25) Total gain recognized in net income $ (10) $ (17) $ (13) $ (25)

Share Repurchases

Share Repurchases	9 Months Ended
	Nov. 02, 2024
Disclosure Share Repurchase Activity [Abstract]
Share Repurchases	Share Repurchases In February 2019, the Company's Board of Directors (the "Board") approved a $1.0 billion share repurchase authorization (the "February 2019 repurchase program"). There were no shares repurchased, excluding shares withheld to settle employee tax withholding payments related to the vesting of stock units, during the 13 and 39 weeks ended November 2, 2024 and October 28, 2023. The February 2019 repurchase program had $476 million remaining as of November 2, 2024. All common stock repurchased is immediately retired.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	9 Months Ended
	Nov. 02, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Weighted-average number of shares used for earnings per share is as follows: 13 Weeks Ended 39 Weeks Ended (shares in millions) November 2, October 28, November 2, October 28, Weighted-average number of shares - basic 377 371 376 369 Common stock equivalents 6 4 7 4 Weighted-average number of shares - diluted 383 375 383 373

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Nov. 02, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies We are a party to a variety of contractual agreements under which we may be obligated to indemnify the other party for certain matters. These contracts primarily relate to our commercial contracts, operating leases, trademarks, intellectual property, financial agreements, and various other agreements. Under these contracts, we may provide certain routine indemnifications relating to representations and warranties (e.g., ownership of assets, environmental or tax indemnifications), or personal injury matters. The terms of these indemnifications range in duration and may not be explicitly defined. Generally, the maximum obligation under such indemnifications is not explicitly stated, and as a result, the overall amount of these obligations cannot be reasonably estimated. Historically, we have not made significant payments for these indemnifications. We believe that if we were to incur a loss in any of these matters, the loss would not have a material effect on our Condensed Consolidated Financial Statements taken as a whole. As a multinational company, we are subject to various proceedings, lawsuits, disputes, and claims ("Actions") arising in the ordinary course of our business. Many of these Actions raise complex factual and legal issues and are subject to uncertainties. As of November 2, 2024, Actions filed against us included commercial, intellectual property, customer, employment, securities, and data privacy claims, including class action lawsuits. The plaintiffs in some Actions seek unspecified damages or injunctive relief, or both. Actions are in various procedural stages and some are covered in part by insurance. As of November 2, 2024, February 3, 2024, and October 28, 2023, we recorded a liability for an estimated loss if the outcome of an Action is expected to result in a loss that is considered probable and reasonably estimable. The liability recorded was not material for any individual Action or in total for all periods presented. Subsequent to November 2, 2024, and through the filing date of this Quarterly Report on Form 10-Q, no information has become available that indicates a change is required that would be material to our Condensed Consolidated Financial Statements taken as a whole. We cannot predict with assurance the outcome of Actions brought against us. However, we do not believe that the outcome of any current Action would have a material effect on our Condensed Consolidated Financial Statements taken as a whole.

Segment Information

Segment Information	9 Months Ended
	Nov. 02, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information We identify our operating segments according to how our business activities are managed and evaluated. As of November 2, 2024, our operating segments included: Old Navy Global, Gap Global, Banana Republic Global, and Athleta Global. Each of our brands serves customer demand through our store and franchise channel and our online channel, leveraging our omni-channel capabilities that allow customers to shop seamlessly across all of our brands. We have determined that each of our operating segments share similar economic and other qualitative characteristics, and therefore the results of our operating segments are aggregated into one reportable segment as of November 2, 2024. We continually monitor and review our segment reporting structure in accordance with authoritative guidance to determine whether any changes have occurred that would impact our reportable segments. See Note 2 of Notes to Condensed Consolidated Financial Statements for disaggregation of revenue by channel and by brand and region.

Divestitures

Divestitures	9 Months Ended
	Nov. 02, 2024
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure	Divestitures On November 7, 2022, we signed agreements to transition our Gap China and Gap Taiwan ("Gap Greater China") operations to a third party, Baozun Inc. ("Baozun"), to operate Gap Greater China stores and the in-market website as a franchise partner, subject to regulatory approvals and closing conditions. On January 31, 2023, the Gap China transaction closed with Baozun. The impact upon divestiture was not material to our results of operations for the 39 weeks ended October 28, 2023. The Gap Taiwan operations will continue to operate as usual until regulatory approvals and closing conditions are met.

Supply Chain Finance Program

Supply Chain Finance Program	9 Months Ended
	Nov. 02, 2024
Supplier Finance Program Liabilities [Abstract]
Supplier Finance Program	Supply Chain Finance Program Our voluntary supply chain finance ("SCF") program provides certain suppliers with the opportunity to sell their receivables due from us to participating financial institutions at the sole discretion of both the suppliers and the financial institutions. We are not a party to the agreements between our suppliers and the financial institutions and our payment terms are not impacted by whether a supplier participates in the SCF program.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Pay vs Performance Disclosure
Net income (loss)	$ 274	$ 218	$ 638	$ 317

Insider Trading Arrangements

Insider Trading Arrangements - shares	3 Months Ended
	Nov. 02, 2024	Oct. 28, 2023
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Mark Breitbard [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On September 19, 2024, Mark Breitbard, President and CEO of Gap brand, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c) to sell up to 964,990 shares of Gap Inc. common stock (all pursuant to unexercised stock options granted from 2017 to 2022). Unless otherwise terminated pursuant to its terms, the plan will terminate on December 31, 2025, or when all shares under the plan are sold.
Name	Mark Breitbard
Title	President and CEO of Gap brand
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 19, 2024
Julie Gruber [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On September 11, 2024, Julie Gruber, Chief Legal and Compliance Officer and Corporate Secretary, modified a trading plan previously adopted on August 29, 2023, intended to satisfy the affirmative defense of Rule 10b5-1(c). Previously, the plan provided for the sale of up to 417,892 shares of Gap Inc. common stock (including 161,804 shares pursuant to unexercised stock options granted from 2014 to 2022). 196,565 shares were sold under the plan before the modification date. As modified, up to 492,578 shares of Gap Inc. common stock may be sold under the plan (including 326,368 shares pursuant to unexercised stock options granted from 2015 to 2020). This figure does not include shares already sold under the plan. Unless otherwise terminated pursuant to its terms, the modified plan will still terminate on September 2, 2025, or when all shares under the plan are sold.
Name	Julie Gruber
Title	Chief Legal and Compliance Officer and Corporate Secretary
Rule 10b5-1 Arrangement Adopted	true	true
Adoption Date	September 11, 2024	August 29, 2023
Aggregate Available	492,578	417,892
Chris Blakeslee [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On September 4, 2024, Chris Blakeslee, President and CEO of Athleta, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c) to sell up to 103,246 shares of Gap Inc. common stock. Unless otherwise terminated pursuant to its terms, the plan will terminate on August 29, 2025, or when all shares under the plan are sold.
Name	Chris Blakeslee
Title	President and CEO of Athleta
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 4, 2024
Aggregate Available	103,246
Katrina O'Connell [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On September 3, 2024, Katrina O'Connell, Chief Financial Officer, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c) to sell up to 550,543 shares of Gap Inc. common stock (including 221,216 shares pursuant to unexercised stock options granted from 2015 to 2022). Unless otherwise terminated pursuant to its terms, the plan will terminate on September 3, 2025, or when all shares under the plan are sold.
Name	Katrina O'Connell
Title	Chief Financial Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 3, 2024
Aggregate Available	550,543
Total pursuant to unexercised stock options [Member] | Mark Breitbard [Member]
Trading Arrangements, by Individual
Aggregate Available	964,990
Total pursuant to unexercised stock options [Member] | Julie Gruber [Member]
Trading Arrangements, by Individual
Aggregate Available	326,368	161,804
Total pursuant to unexercised stock options [Member] | Katrina O'Connell [Member]
Trading Arrangements, by Individual
Aggregate Available	221,216

Accounting Policies (Tables)

Accounting Policies (Tables)	9 Months Ended
	Nov. 02, 2024
Supplemental Cash Flow Elements [Abstract]
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]	As of November 2, 2024, February 3, 2024, and October 28, 2023, restricted cash primarily included consideration that serves as collateral for our insurance obligations and certain other obligations occurring in the normal course of business. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within our Condensed Consolidated Balance Sheets to the total shown on our Condensed Consolidated Statements of Cash Flows: ($ in millions) November 2, February 3, October 28, Cash and cash equivalents, per Condensed Consolidated Balance Sheets $ 1,969 $ 1,873 $ 1,351 Restricted cash included in other long-term assets 29 28 28 Total cash, cash equivalents, and restricted cash, per Condensed Consolidated Statements of Cash Flows $ 1,998 $ 1,901 $ 1,379

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Nov. 02, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue [Table Text Block]	Net sales disaggregated by channel are as follows: 13 Weeks Ended 39 Weeks Ended ($ in millions) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Store and franchise sales $ 2,289 $ 2,331 $ 6,871 $ 6,771 Online sales (1) 1,540 1,436 4,066 3,820 Total net sales $ 3,829 $ 3,767 $ 10,937 $ 10,591 __________ (1)
Net Sales by Brand and Region	Net sales disaggregated by brand and region are as follows: ($ in millions) Old Navy Global Gap Global Banana Republic Global Athleta Global Other (2) Total 13 Weeks Ended November 2, 2024 U.S. (1) $ 1,949 $ 683 $ 406 $ 281 $ 21 $ 3,340 Canada 190 95 43 9 — 337 Other regions 11 121 20 — — 152 Total $ 2,150 $ 899 $ 469 $ 290 $ 21 $ 3,829 ($ in millions) Old Navy Global Gap Global Banana Republic Global Athleta Global Other (2) Total 13 Weeks Ended October 28, 2023 U.S. (1) $ 1,917 $ 664 $ 398 $ 267 $ 15 $ 3,261 Canada 193 96 42 10 — 341 Other regions 16 127 20 2 — 165 Total $ 2,126 $ 887 $ 460 $ 279 $ 15 $ 3,767 ($ in millions) Old Navy Global Gap Global Banana Republic Global Athleta Global Other (2) Total 39 Weeks Ended November 2, 2024 U.S. (1) $ 5,663 $ 1,775 $ 1,203 $ 926 $ 49 $ 9,616 Canada 495 238 122 29 — 884 Other regions 31 341 63 2 — 437 Total $ 6,189 $ 2,354 $ 1,388 $ 957 $ 49 $ 10,937 ($ in millions) Old Navy Global Gap Global Banana Republic Global Athleta Global Other (2) Total 39 Weeks Ended October 28, 2023 U.S. (1) $ 5,353 $ 1,702 $ 1,187 $ 903 $ 29 $ 9,174 Canada 503 233 122 33 — 891 Other regions 59 399 63 5 — 526 Total $ 5,915 $ 2,334 $ 1,372 $ 941 $ 29 $ 10,591 __________ (1) U.S. includes the United States and Puerto Rico. (2) Primarily consists of net sales from revenue-generating strategic initiatives.

Debt and Credit Facilities Long

Debt and Credit Facilities Long Term Debt (Tables)	9 Months Ended
	Nov. 02, 2024
Debt Disclosure [Abstract]
Long Term Debt	Long-term debt recorded on the Condensed Consolidated Balance Sheets consists of the following: ($ in millions) November 2, February 3, October 28, 2029 Notes $ 750 $ 750 $ 750 2031 Notes 750 750 750 Less: Unamortized debt issuance costs (11) (12) (12) Total long-term debt $ 1,489 $ 1,488 $ 1,488
Schedule of Maturities of Long-term Debt [Table Text Block]	The scheduled maturity of the Senior Notes is as follows: Scheduled Maturity ($ in millions) Principal Interest Rate Interest Payments October 1, 2029 (1) $ 750 3.625 % Semi-Annual October 1, 2031 (2) 750 3.875 % Semi-Annual Total issuance $ 1,500 __________ (1) On or after October 1, 2024, includes an option to redeem the 2029 Notes, in whole or in part at any time, at stated redemption prices. (2) Includes an option to redeem the 2031 Notes, in whole or in part at any time, subject to a make-whole premium, prior to October 1, 2026. On or after October 1, 2026, includes an option to redeem the 2031 Notes, in whole or in part at any time, at stated redemption prices.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Nov. 02, 2024
Fair Value Disclosures [Abstract]
Financial Assets And Liabilities Measured At Fair Value On Recurring Basis	Financial assets and liabilities measured at fair value on a recurring basis and cash equivalents are as follows: Fair Value Measurements at Reporting Date Using ($ in millions) November 2, 2024 Quoted Prices in Significant Other Significant Assets: Cash equivalents $ 8 $ 1 $ 7 $ — Short-term investments 250 130 120 — Derivative financial instruments 19 — 19 — Deferred compensation plan assets 38 38 — — Other assets 4 — — 4 Total $ 319 $ 169 $ 146 $ 4 Liabilities: Derivative financial instruments $ 1 $ — $ 1 $ — Fair Value Measurements at Reporting Date Using ($ in millions) February 3, 2024 Quoted Prices in Significant Other Significant Assets: Cash equivalents $ 1 $ — $ 1 $ — Derivative financial instruments 7 — 7 — Deferred compensation plan assets 31 31 — — Other assets 4 — — 4 Total $ 43 $ 31 $ 8 $ 4 Liabilities: Derivative financial instruments $ 8 $ — $ 8 $ — Fair Value Measurements at Reporting Date Using ($ in millions) October 28, 2023 Quoted Prices in Significant Other Significant Assets: Cash equivalents $ 1 $ — $ 1 $ — Derivative financial instruments 34 — 34 — Deferred compensation plan assets 31 31 — — Other assets 4 — — 4 Total $ 70 $ 31 $ 35 $ 4 Liabilities: Derivative financial instruments $ — $ — $ — $ —

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Nov. 02, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Foreign Exchange Forward Contracts Outstanding	We had foreign exchange forward contracts outstanding in the following notional amounts: ($ in millions) November 2, February 3, October 28, Derivatives designated as cash flow hedges $ 458 $ 381 $ 357 Derivatives not designated as hedging instruments 427 568 526 Total $ 885 $ 949 $ 883
Fair Values of Asset and Liability Derivative Financial Instruments	The fair values of foreign exchange forward contracts are as follows: ($ in millions) November 2, February 3, October 28, Derivatives designated as cash flow hedges: Other current assets $ 10 $ 6 $ 13 Other long-term assets 1 — 2 Accrued expenses and other current liabilities — 2 — Derivatives not designated as hedging instruments: Other current assets 8 1 19 Accrued expenses and other current liabilities 1 6 — Total derivatives in an asset position $ 19 $ 7 $ 34 Total derivatives in a liability position $ 1 $ 8 $ —
Effects of Derivative Financial Instruments on OCI and Condensed Consolidated Statements of Income	The pre-tax amounts recognized in net income related to derivative instruments are as follows: Location and Amount of Gain 13 Weeks Ended 13 Weeks Ended ($ in millions) Cost of goods sold and occupancy expenses Operating expenses Cost of goods sold and occupancy expenses Operating expenses Total amount of expense line items presented in the Condensed Consolidated Statements of Operations in which the effects of derivatives are recorded $ 2,194 $ 1,280 $ 2,211 $ 1,306 Gain recognized in net income Derivatives designated as cash flow hedges (4) — (6) — Derivatives not designated as hedging instruments — (4) — (27) Total gain recognized in net income $ (4) $ (4) $ (6) $ (27) Location and Amount of Gain 39 Weeks Ended 39 Weeks Ended ($ in millions) Cost of goods sold and occupancy expense Operating expenses Cost of goods sold and occupancy expense Operating expenses Total amount of expense line items presented in the Condensed Consolidated Statements of Operations in which the effects of derivatives are recorded $ 6,322 $ 3,762 $ 6,488 $ 3,757 Gain recognized in net income Derivatives designated as cash flow hedges (10) — (13) — Derivatives not designated as hedging instruments — (17) — (25) Total gain recognized in net income $ (10) $ (17) $ (13) $ (25)

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	9 Months Ended
	Nov. 02, 2024
Earnings Per Share [Abstract]
Weighted-Average Number of Shares	Weighted-average number of shares used for earnings per share is as follows: 13 Weeks Ended 39 Weeks Ended (shares in millions) November 2, October 28, November 2, October 28, Weighted-average number of shares - basic 377 371 376 369 Common stock equivalents 6 4 7 4 Weighted-average number of shares - diluted 383 375 383 373

Accounting Policies Supplementa

Accounting Policies Supplemental Cash Flow Disclosures (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023	Jan. 28, 2023
Restricted Cash and Cash Equivalents Items [Line Items]
Cash and cash equivalents	$ 1,969	$ 1,873	$ 1,351
Restricted Cash, Noncurrent	29	28	28
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents end of period	1,998	1,901	1,379	$ 1,273
Reconciliation of Cash Flow Cash, Cash Equiv. and Restricted Cash to Balance Sheet
Restricted Cash and Cash Equivalents Items [Line Items]
Cash and cash equivalents	1,969	1,873	1,351
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents end of period	$ 1,998	$ 1,901	$ 1,379

Revenue Disaggregation (Details

Revenue Disaggregation (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Disaggregation of Revenue
Revenues		$ 3,829	$ 3,767	$ 10,937	$ 10,591
Store and Franchise Sales
Disaggregation of Revenue
Revenues		2,289	2,331	6,871	6,771
Online Sales
Disaggregation of Revenue
Revenues	[1]	$ 1,540	$ 1,436	$ 4,066	$ 3,820
[1] Online sales primarily include sales originating from our online channel including those that are picked up or shipped from stores and net sales from revenue-generating strategic initiatives.

Net Sales by Brand and Region (

Net Sales by Brand and Region (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		$ 3,829	$ 3,767	$ 10,937	$ 10,591
Old Navy
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		2,150	2,126	6,189	5,915
Gap
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		899	887	2,354	2,334
Banana Republic [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		469	460	1,388	1,372
Athleta [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		290	279	957	941
Other entities [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales	[1]	21	15	49	29
U.S.
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales	[2]	3,340	3,261	9,616	9,174
U.S. | Old Navy
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales	[2]	1,949	1,917	5,663	5,353
U.S. | Gap
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales	[2]	683	664	1,775	1,702
U.S. | Banana Republic [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales	[2]	406	398	1,203	1,187
U.S. | Athleta [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales	[2]	281	267	926	903
U.S. | Other entities [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales	[1],[2]	21	15	49	29
Canada
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		337	341	884	891
Canada | Old Navy
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		190	193	495	503
Canada | Gap
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		95	96	238	233
Canada | Banana Republic [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		43	42	122	122
Canada | Athleta [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		9	10	29	33
Canada | Other entities [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales	[1]	0	0	0	0
Other Regions
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		152	165	437	526
Other Regions | Old Navy
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		11	16	31	59
Other Regions | Gap
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		121	127	341	399
Other Regions | Banana Republic [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		20	20	63	63
Other Regions | Athleta [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales		0	2	2	5
Other Regions | Other entities [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net Sales	[1]	$ 0	$ 0	$ 0	$ 0
[1] Primarily consists of net sales from revenue-generating strategic initiatives. U.S. includes the United States and Puerto Rico.

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023	Aug. 03, 2024	Feb. 03, 2024	Jul. 29, 2023	Jan. 28, 2023	Apr. 30, 2022
Revenue from Contract with Customer [Abstract]
Liabilities, Other than Long-term Debt, Noncurrent									$ 60
Deferred Revenue, Revenue Recognized	$ 95	$ 119	$ 209	$ 227
Deferred Revenue, Current	$ 260	$ 315	$ 260	$ 315	$ 280	$ 337	$ 327	$ 354

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details)	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Income Tax Disclosure [Abstract]
Effective Income Tax Rate, Percent	24.10%	12.80%	26.20%	6.20%

Debt and Credit Facilities Lo_2

Debt and Credit Facilities Long Term Debt (Details) - USD ($) $ in Millions	Nov. 02, 2024		Feb. 03, 2024	Oct. 28, 2023
Debt Instrument [Line Items]
Notes	$ 1,489		$ 1,488	$ 1,488
Total long-term debt	1,489		1,488	1,488
Unamortized Debt Issuance Expense	(11)		(12)	(12)
Debt Instrument, Face Amount	1,500
2029 Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	750	[1]	750	750
2031 Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 750	[2]	$ 750	$ 750
[1] On or after October 1, 2024, includes an option to redeem the 2029 Notes, in whole or in part at any time, at stated redemption prices. Includes an option to redeem the 2031 Notes, in whole or in part at any time, subject to a make-whole premium, prior to October 1, 2026. On or after October 1, 2026, includes an option to redeem the 2031 Notes, in whole or in part at any time, at stated redemption prices.

Debt and Credit Facilities Sche

Debt and Credit Facilities Scheduled Maturity of Notes (Details) - USD ($) $ in Millions	9 Months Ended
	Nov. 02, 2024		Feb. 03, 2024	Oct. 28, 2023
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 1,500
2031 Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 750	[1]	$ 750	$ 750
Debt Instrument, Interest Rate, Stated Percentage	3.875%
Debt Instrument, Payment Terms	Semi-Annual
2029 Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 750	[2]	$ 750	$ 750
Debt Instrument, Interest Rate, Stated Percentage	3.625%
Debt Instrument, Payment Terms	Semi-Annual
[1] Includes an option to redeem the 2031 Notes, in whole or in part at any time, subject to a make-whole premium, prior to October 1, 2026. On or after October 1, 2026, includes an option to redeem the 2031 Notes, in whole or in part at any time, at stated redemption prices. On or after October 1, 2024, includes an option to redeem the 2029 Notes, in whole or in part at any time, at stated redemption prices.

Debt and Credit Facilities - Ad

Debt and Credit Facilities - Additional Information (Details) - USD ($) $ in Millions	Nov. 02, 2024		Feb. 03, 2024	Oct. 28, 2023
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 1,500
Estimated fair value	1,310
2029 Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 750	[1]	$ 750	$ 750
Debt Instrument, Interest Rate, Stated Percentage	3.625%
2031 Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 750	[2]	750	750
Debt Instrument, Interest Rate, Stated Percentage	3.875%
ABL Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum borrowing capacity	$ 2,200
Unsecured committed letter of credit amount	47
Long-term Line of Credit	$ 0		$ 0	$ 0
[1] On or after October 1, 2024, includes an option to redeem the 2029 Notes, in whole or in part at any time, at stated redemption prices. Includes an option to redeem the 2031 Notes, in whole or in part at any time, subject to a make-whole premium, prior to October 1, 2026. On or after October 1, 2026, includes an option to redeem the 2031 Notes, in whole or in part at any time, at stated redemption prices.

Fair Value Measurements - Finan

Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Assets:
Cash equivalents	$ 8	$ 1	$ 1
Short-term investments	250	0	0
Derivative financial instruments	19	7	34
Deferred compensation plan assets	38	31	31
Other Assets, Fair Value Disclosure	4	4	4
Total	319	43	70
Liabilities:
Derivative financial instruments	1	8	0
Fair Value, Inputs, Level 1 [Member]
Assets:
Cash equivalents	1	0	0
Short-term investments	130
Derivative financial instruments	0	0	0
Deferred compensation plan assets	38	31	31
Other Assets, Fair Value Disclosure	0	0	0
Total	169	31	31
Liabilities:
Derivative financial instruments	0	0	0
Fair Value, Inputs, Level 2 [Member]
Assets:
Cash equivalents	7	1	1
Short-term investments	120
Derivative financial instruments	19	7	34
Deferred compensation plan assets	0	0	0
Other Assets, Fair Value Disclosure	0	0	0
Total	146	8	35
Liabilities:
Derivative financial instruments	1	8	0
Fair Value, Inputs, Level 3 [Member]
Assets:
Cash equivalents	0	0	0
Short-term investments	0
Derivative financial instruments	0	0	0
Deferred compensation plan assets	0	0	0
Other Assets, Fair Value Disclosure	4	4	4
Total	4	4	4
Liabilities:
Derivative financial instruments	$ 0	$ 0	$ 0

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023	Feb. 03, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Purchases, sales, issuances, or settlements related to recurring level 3 measurements	$ 0	$ 0	$ 0	$ 0
Short-term investments	250,000,000	$ 0	250,000,000	$ 0	$ 0
Debt Securities, Available-for-sale, Unrealized Gain (Loss)	0		0
Debt Securities, Available-for-Sale, Realized Gain (Loss)	$ 0		$ 0

Fair Value Measurements Impairm

Fair Value Measurements Impairments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Long Lived Assets [Line Items]
Goodwill, Impairment Loss	$ 0	$ 0	$ 0	$ 0
Other indefinite-lived intangible assets impairment charges	0	0	0	0
Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale	0		0
Total Impairment Charges	$ 0	$ 0	$ 0	$ 0

Derivative Financial Instrume_3

Derivative Financial Instruments - Foreign Exchange Contracts Outstanding to Sell Various Currencies (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Derivative [Line Items]
Derivative, Notional Amount	$ 885	$ 949	$ 883
Derivatives in cash flow hedging relationships
Derivative [Line Items]
Derivative, Notional Amount	458	381	357
Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative, Notional Amount	$ 427	$ 568	$ 526

Derivative Financial Instrume_4

Derivative Financial Instruments - Fair Values of Asset and Liability Derivative Financial Instruments (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Derivatives, Fair Value [Line Items]
Derivative financial instruments, assets	$ 19	$ 7	$ 34
Derivative financial instruments, liabilities	1	8	0
Foreign Exchange Forward Contract
Derivatives, Fair Value [Line Items]
Derivative financial instruments, assets	19	7	34
Derivative financial instruments, liabilities	1	8	0
Derivatives in cash flow hedging relationships | Foreign Exchange Forward Contract | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative financial instruments, assets	10	6	13
Derivatives in cash flow hedging relationships | Foreign Exchange Forward Contract | Other Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative financial instruments, assets	1	0	2
Derivatives in cash flow hedging relationships | Foreign Exchange Forward Contract | Accrued Liabilities Current [Member]
Derivatives, Fair Value [Line Items]
Derivative financial instruments, liabilities	0	2	0
Not Designated as Hedging Instrument | Foreign Exchange Forward Contract | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative financial instruments, assets	8	1	19
Not Designated as Hedging Instrument | Foreign Exchange Forward Contract | Accrued Liabilities Current [Member]
Derivatives, Fair Value [Line Items]
Derivative financial instruments, liabilities	$ 1	$ 6	$ 0

Derivative Financial Instrume_5

Derivative Financial Instruments - Effects Of Derivative Financial Instruments On OCI And Condensed Consolidated Statements Of Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Derivative Instruments, (Gain) Loss [Line Items]
Cost of goods sold and occupancy expenses	$ 2,194	$ 2,211	$ 6,322	$ 6,488
Operating Expenses	1,280	1,306	3,762	3,757
Cost of Goods Sold and Occupancy Expense
Derivative Instruments, (Gain) Loss [Line Items]
(Gain) loss reclassified from accumulated OCI into income, effective portion, net	(4)	(6)	(10)	(13)
Operating Expenses [Member]
Derivative Instruments, (Gain) Loss [Line Items]
(Gain) loss reclassified from accumulated OCI into income, effective portion, net	(4)	(27)	(17)	(25)
Foreign Exchange Forward Contract | Cost of Goods Sold and Occupancy Expense | Not Designated as Hedging Instrument
Derivative Instruments, (Gain) Loss [Line Items]
(Gain) loss reclassified from accumulated OCI into income, effective portion, net	0	0	0	0
Foreign Exchange Forward Contract | Cost of Goods Sold and Occupancy Expense | Derivatives in cash flow hedging relationships
Derivative Instruments, (Gain) Loss [Line Items]
(Gain) loss reclassified from accumulated OCI into income, effective portion, net	(4)	(6)	(10)	(13)
Foreign Exchange Forward Contract | Operating Expenses [Member] | Not Designated as Hedging Instrument
Derivative Instruments, (Gain) Loss [Line Items]
(Gain) loss reclassified from accumulated OCI into income, effective portion, net	(4)	(27)	(17)	(25)
Foreign Exchange Forward Contract | Operating Expenses [Member] | Derivatives in cash flow hedging relationships
Derivative Instruments, (Gain) Loss [Line Items]
(Gain) loss reclassified from accumulated OCI into income, effective portion, net	$ 0	$ 0	$ 0	$ 0

Derivative Financial Instrume_6

Derivative Financial Instruments - Additional Information (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Derivative [Line Items]
Amounts Subject to Enforceable Master Netting Arrangements	$ 0	$ 0	$ 0

Share Repurchase Activity (Deta

Share Repurchase Activity (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023	Feb. 26, 2019
Disclosure Share Repurchase Activity [Abstract]
Number of shares repurchased	0	0	0	0
Stock Repurchase Program, Authorized Amount					$ 1,000
Share repurchases, remaining amount	$ 476		$ 476

Earnings (Loss) Per Share - Wei

Earnings (Loss) Per Share - Weighted Average Number of Shares (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Earnings Per Share [Abstract]
Weighted-average number of shares - basic (in shares)	377	371	376	369
Common stock equivalents (in shares)	6	4	7	4
Weighted-average number of shares - diluted (in shares)	383	375	383	373

Earnings (Loss) Per Share - Add

Earnings (Loss) Per Share - Additional Information (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Earnings Per Share [Abstract]
Shares excluded from the computations of weighted-average number of shares - diluted	2	5	3	6

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Commitments and Contingencies [Line Items]
Loss Contingency, Estimate of Possible Loss	$ 0	$ 0	$ 0

Segment Information - Additiona

Segment Information - Additional Information (Details)	9 Months Ended
	Nov. 02, 2024 Segment
Segment Reporting [Abstract]
Number of reportable segments (in segments)	1

Divestitures - Additional Infor

Divestitures - Additional Information (Details) - USD ($) $ in Millions	9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net proceeds from sale of building	$ 0	$ 76
Gain (Loss) on Disposition of Property Plant Equipment	$ 0	$ 47

Supply Chain Finance Program (D

Supply Chain Finance Program (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Supplier Finance Program Liabilities [Abstract]
Supplier Finance Program, Obligation, Current	$ 350	$ 373	$ 344